COURT-RULING ·Filed Aug 27, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed1mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

This filing is a routine procedural order with no trading implications. Monitor for any substantive rulings in the underlying case (Kaiser v. Merck) that could affect Merck's liability exposure.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
MRK ▼ -0.51% at T+20d
NEUTRAL call ✗ call lost -0.51% · α vs SPY -0.54% · entry $149.54 → $148.78
Next anchor: T+60d in 7w
Latest observation: T+22 -1.97% FF3 residual α
Entry anchored
Aug 26, 07:57 PM ET
via 1-min bar
T+1d
-0.80%
call -0.80% · α -0.57%
$148.35
settled 5w ago
T+5d
+1.87%
call +1.87% · α +1.60%
$152.34
settled 4w ago
T+20d
-0.51%
call -0.51% · α -0.54%
$148.78
settled 8d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

This is a routine procedural order granting an attorney's application to appear pro hac vice in a pending case (Kaiser Foundation Health Plan v. Merck & Co., Inc.) in the Northern District of California. The order does not address the merits of the litigation, award any damages, or impose any injunctive relief. It has no material impact on Merck's business, financials, or stock price.

Court Ruling Details

Ruling Date
Aug 27, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Case Type
other
Ruling Type
procedural
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Key Facts

  • The court granted an attorney's application to appear pro hac vice in the case Kaiser Foundation Health Plan Inc v. Merck & Company Inc. et al.
  • The ruling is purely procedural—no substantive legal issue was decided.
  • No damages, injunction, or financial exposure was mentioned in the order.

Financial Impact

None—purely procedural order with no financial impact.

Risk Factors

  • The underlying case (Kaiser v. Merck) could eventually produce a material ruling, but this order does not change that risk profile.

Market Snapshot

Price
$148.37
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-11e7d9d153-MRK
20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.57 (−0.25%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.57 (−2.68%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.57 (−3.99%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.57 (+4.71%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.57 (−3.64%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.57 (+5.69%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.57 (+5.92%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.57 (+5.92%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.57 (+8.01%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.57 (+8.01%)
Showing 10 of 20

US Market Status

Market Open — Closes in 6h 26m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access